Alireza Ghaffarinejad (Shokouh Arjmand)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Venues

European psychiatry : the journal of the Association of European Psychiatrists

Basic & clinical pharmacology & toxicology

ACS pharmacology & translational science

The British journal of psychiatry : the journal of mental science

Kerman Neuroscience Research Center

Aarhus University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Kerman Neuroscience Research Center

Iran

Research Assistant

Education History

Aarhus University Sep 01 2020

Denmark

PHD

Publications

Alireza Ghaffarinejad, Mehran Ilaghi, Ali Karimi Sisakht, Matti Bock Guldager, Gregers Wegener, Anne M Landau, Albert Gjedde
Regulation of mitochondrial dysfunction by estrogens and estrogen receptors in Alzheimer's disease: A focused review. Basic & clinical pharmacology & toxicology (2024)
Alireza Ghaffarinejad, Mehran Ilaghi, Ali Karimi Sisakht, Matti Bock Guldager, Gregers Wegener, Anne M Landau, Albert Gjedde
Regulation of mitochondrial dysfunction by estrogens and estrogen receptors in Alzheimer's disease: A focused review. Basic & clinical pharmacology & toxicology 135 (2) (2024)
Alireza Ghaffarinejad, Matti Bock Guldager, Gregers Wegener
All psychiatric disorders are equal, but some are more equal than others! An unconscious bias that calls for precision terminology. The British journal of psychiatry : the journal of mental science 225 (1) (2024)
Alireza Ghaffarinejad, Caroline Biojone, Gregers Wegener
Modulation of Leucine Sensors to Mitigate Antipsychotics-Induced Metabolic Syndrome: A New Vista. ACS pharmacology & translational science 7 (1) (2023)
Alireza Ghaffarinejad, Rodrigo Grassi-Oliveira, Gregers Wegener
Rethinking treatment-resistant depression to quasi-tenacious depression. European psychiatry : the journal of the Association of European Psychiatrists 66 (1) (2023)
Alireza Ghaffarinejad, Rodrigo Grassi-Oliveira, Gregers Wegener
Rethinking treatment-resistant depression to quasi-tenacious depression. European psychiatry : the journal of the Association of European Psychiatrists 66 (1) (2023)
Alireza Ghaffarinejad, Rodrigo Grassi-Oliveira, Gregers Wegener
Rethinking treatment-resistant depression to quasi-tenacious depression. European psychiatry : the journal of the Association of European Psychiatrists 66 (1) (2023)
Alireza Ghaffarinejad, Rodrigo Grassi-Oliveira, Gregers Wegener
Rethinking treatment-resistant depression to quasi-tenacious depression. European psychiatry : the journal of the Association of European Psychiatrists 66 (1) (2023)
Alireza Ghaffarinejad, Rodrigo Grassi-Oliveira, Gregers Wegener
Rethinking treatment-resistant depression (TRD) to quasi-tenacious depression (QTD). European psychiatry : the journal of the Association of European Psychiatrists (2023)
Alireza Ghaffarinejad, Caroline Biojone, Gregers Wegener
Modulation of Leucine Sensors to Mitigate Antipsychotics-Induced Metabolic Syndrome: A New Vista. ACS pharmacology & translational science 7 (1) (2023)
Alireza Ghaffarinejad, Dirk Bender, Steen Jakobsen, Gregers Wegener, Anne Marlene Landau
Peering into the Brain's Estrogen Receptors: PET Tracers for Visualization of Nuclear and Extranuclear Estrogen Receptors in Brain Disorders. Biomolecules 13 (9) (2023)
Alireza Ghaffarinejad, Rodrigo Grassi-Oliveira, Gregers Wegener
Rethinking treatment-resistant depression to quasi-tenacious depression. European psychiatry : the journal of the Association of European Psychiatrists 66 (1) (2023)
Alireza Ghaffarinejad, Anne Marlene Landau, Bardia Varastehmoradi, Roberto Andreatini, Sâmia Regiane Lourenço Joca, Gregers Wegener
The intersection of astrocytes and the endocannabinoid system in the lateral habenula: on the fast-track to novel rapid-acting antidepressants. Molecular psychiatry 27 (8) (2022)
Alireza Ghaffarinejad, Gregers Wegener, Anne M Landau, Amanda Eskelund
Tips and traps for behavioural animal experimentation. Acta neuropsychiatrica 34 (5) (2022)
Shahrzad Mazhari, Alireza Ghaffarinejad, Mahin Eslami Shahrbabaki, Elham Karimi Ghoughari
Comparing Copper Serum Level and Cognitive Functioning in Patients With Schizophrenia and Healthy Controls. Basic and clinical neuroscience 11 (5) (2020)
Alireza Ghaffarinejad, Niloufar Sattari, Farzaneh Raaii, Shokouh Arjmand
Validity and reliability of a Persian version of the Dissociative Experiences Scale II (DES-II) on Iranian patients diagnosed with schizophrenia and mood disorders. Journal of trauma & dissociation : the official journal of the International Society for the Study of Dissociation (ISSD) 21 (3) (2019)

Alireza Ghaffarinejad.css-eqlu8i{font-size:small;padding-left:4px;} (Shokouh Arjmand)

Publication Activity (10 Years)

Top Topics

Top Venues

Alireza Ghaffarinejad (Shokouh Arjmand)